Peripheral endothelial dysfunction is a novel risk factor for systolic dysfunction and heart failure progression

BACKGROUND: ACC/AHA guidelines recognize the progressive nature of heart failure (HF). Patients with risk factors (Stage A) are at risk for developing asymptomatic cardiac dysfunction (Stage B), which may then lead to symptomatic HF (Stage C). As such, therapies targeting abnormalities in stages A a...

Descripción completa

Detalles Bibliográficos
Autores principales: Taher, Riad, Sara, Jaskanwal D., Toya, Takumi, Borlaug, Barry A., Lerman, Lilach O., Lerman, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385446/
https://www.ncbi.nlm.nih.gov/pubmed/32743042
http://dx.doi.org/10.1016/j.ijcha.2020.100584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385446/
https://www.ncbi.nlm.nih.gov/pubmed/32743042
http://dx.doi.org/10.1016/j.ijcha.2020.100584

Ejemplares similares